- Home
- JAZZ vs BROS Comparison
JAZZ vs BROS Comparison
Compare JAZZ & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- BROS
- Stock Information
- Founded
- JAZZ 2003
- BROS 1992
- Country
- JAZZ Ireland
- BROS United States
- Employees
- JAZZ N/A
- BROS N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- BROS Restaurants
- Sector
- JAZZ Health Care
- BROS Consumer Discretionary
- Exchange
- JAZZ Nasdaq
- BROS Nasdaq
- Market Cap
- JAZZ 7.9B
- BROS 7.4B
- IPO Year
- JAZZ 2007
- BROS 2021
- Fundamental
- Price
- JAZZ $136.58
- BROS $47.71
- Analyst Decision
- JAZZ Strong Buy
- BROS Strong Buy
- Analyst Count
- JAZZ 14
- BROS 18
- Target Price
- JAZZ $179.21
- BROS $80.83
- AVG Volume (30 Days)
- JAZZ 758.5K
- BROS 3.9M
- Earning Date
- JAZZ 11-05-2025
- BROS 11-05-2025
- Dividend Yield
- JAZZ N/A
- BROS N/A
- EPS Growth
- JAZZ N/A
- BROS 75.89
- EPS
- JAZZ N/A
- BROS 0.48
- Revenue
- JAZZ $4,086,695,000.00
- BROS $1,451,963,000.00
- Revenue This Year
- JAZZ $5.70
- BROS $27.79
- Revenue Next Year
- JAZZ $6.16
- BROS $24.86
- P/E Ratio
- JAZZ N/A
- BROS $99.45
- Revenue Growth
- JAZZ 4.52
- BROS 29.80
- 52 Week Low
- JAZZ $95.49
- BROS $30.49
- 52 Week High
- JAZZ $148.06
- BROS $86.88
- Technical
- Relative Strength Index (RSI)
- JAZZ 63.56
- BROS 24.12
- Support Level
- JAZZ $125.79
- BROS $51.12
- Resistance Level
- JAZZ $140.39
- BROS $52.68
- Average True Range (ATR)
- JAZZ 3.18
- BROS 1.80
- MACD
- JAZZ 0.46
- BROS -0.70
- Stochastic Oscillator
- JAZZ 71.59
- BROS 2.25
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.